N4 Pharma Share Discussion Threads

[dplewis1] 03/7/2024 07:32

Boom finally revenue generating!! Oh no wait they just filed another application

[johno1977] 19/6/2024 18:18

Why should he add every time. Grow up you two.

[nobbygnome] 19/6/2024 07:04

Double post

[nobbygnome] 19/6/2024 07:04

So he wasn’t confident enough to put in more money at this lowly level despite ramping here

[dplewis1] 19/6/2024 06:03

Dilution Dave .. shocker

[nobbygnome] 07/6/2024 14:19

Wow yet another sucker punch for shareholders! Where are those deals which were promised by the resident ramper? He must be rather upset with Nigel….

[dplewis1] 07/6/2024 14:16

25% down and diluted to oblivion. Great stuff Nigel.. no wonder he hasn't bought any more shares in ages..lol

[earwacks] 07/6/2024 09:34

Best mates ne more

[dplewis1] 07/6/2024 09:21

Oh no Dave .. Nigel's had you over again! How many times??!

[dplewis1] 23/5/2024 11:38

All resolutions to watch the share price plop under half a penny were passed

[pwal] 23/5/2024 10:58

SRI works with N4 Pharma to target and treat cells in the human body that had been unreachablePaving the way for targeted treatments, the collaboration aims to help realize the full potential of precision healthcare.

[vlad the impaler] 12/5/2024 08:38

next drop 29-39% from current price

[tankerton] 12/5/2024 08:20

Here is the list of pharma companies participating in the Bio Conference in San Diego in which SRI will be marketing Nuvec to the pharma community around the world between June 3-6.

[fydo] 09/5/2024 12:02

How does N4 Pharma plan to navigate the regulatory approval process with regulatory bodies such as the FDA?
The Food and Drug Administration (FDA) has authority to grant orphan drug designation (ODD) to a drug or biological product to prevent, diagnose or treat a rare disease or condition. Being granted ODD can provide various benefits including market exclusivity, tax incentives, eligibility for grants, accelerated approval process and regulatory fee waivers. ODD aims to expedite the development of promising therapies by providing increased support and an accelerated regulatory framework.

[jusjusjus] 25/4/2024 09:43

I would hope so with the wider exposure to the market this collaboration brings!

[pwal] 25/4/2024 09:34

Is this collaboration going to help funding?

[jusjusjus] 25/4/2024 06:57

Turned out to be coming days!

[pwal] 23/4/2024 10:53

You are right: In the coming weeks as stated later in the report. That would be great news.

[pwal] 23/4/2024 09:16

Did they say in the coming weeks or in the near future?